ETCTN A Randomized Phase II Trial of MLN4924 (Pevonedistat) with Azacitidine versus Azacitidine in Adult Relapsed or Refractory Acute Myeloid Leukemia Adult CIRB - Early Phase Emphasis Administratively Completed Completed